Neuropeptides in the cerebrospinal fluid and regulation of behavior.
Institute of Physiology, Medical School of Magdeburg, Germany.
H
H
Schwarzberg
M
M
Pross
D000324:Adrenocorticotropic Hormone / Q000008:administration & dosage / Q000494:pharmacology*; D000818:Animals; D001127:Arginine Vasopressin / Q000008:administration & dosage / Q000494:pharmacology*; D001362:Avoidance Learning / Q000187:drug effects*; D002552:Cerebral Ventricles / Q000187:drug effects / Q000502:physiology*; D004347:Drug Interactions; D004597:Electroshock; D007276:Injections, Intraventricular; D008297:Male; D009479:Neuropeptides / Q000134:cerebrospinal fluid*; D018377:Neurotransmitter Agents / Q000008:administration & dosage / Q000494:pharmacology*; D009842:Oligopeptides / Q000008:administration & dosage / Q000494:pharmacology*; D010446:Peptide Fragments / Q000008:administration & dosage / Q000494:pharmacology*; D051381:Rats; D017208:Rats, Wistar
D009479:Neuropeptides; D018377:Neurotransmitter Agents; D009842:Oligopeptides; D010446:Peptide Fragments; D001127:Arginine Vasopressin; C011536:proctolin; D000324:Adrenocorticotropic Hormone; C011394:ACTH (4-10)